# FDA Inspection 552512 - Biomat USA, Inc. - December 12, 2008

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/54834491-8228-448f-b8de-436ca78e4e4d
Source feed: FDA_Inspections

> FDA Inspection 552512 for Biomat USA, Inc. on December 12, 2008. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 552512
- Company Name: Biomat USA, Inc.
- Inspection Date: 2008-12-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1068977 - 2018-09-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b29c4fff-0b14-4bc7-bc26-83968879f22d)
- [FDA Inspection 869867 - 2014-03-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8d456c57-b410-4a64-b9bd-2ef635250cf5)
- [FDA Inspection 800223 - 2012-09-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3f0dda29-65e9-4c5c-96d8-f86d2fd9d035)
- [FDA Inspection 697740 - 2010-11-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1ff520c9-1b69-4c9a-82a8-edce02799a7e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/59b65d27-be46-4ab1-b15e-6f27b3d7b0cf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d